(Q34159155)

31 July 2017

title

Dipyrone and agranulocytosis: what is the risk? (English)

1 reference

31 July 2017

1 reference

Jayne E Edwards

1

1 reference

31 July 2017

Henry J McQuay

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

360

1 reference

31 July 2017

issue

9344

1 reference

31 July 2017

page(s)

1438

1 reference

To use or not to use dipyrone? Or maybe, Central Station versus ER? That is the question

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

A population-based case-cohort study of drug-associated agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

Propofol and bradycardia: causation, frequency and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911489-9

7 January 2021

10.1016/S0140-6736(02)11489-9

Identifiers

DOI

1 reference

31 July 2017

1 reference